Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Japan Pockets $5.3M in Stock Placement

NEW YORK (GenomeWeb News) — Third Wave Japan, a subsidiary of Third Wave Technologies, has raised roughly $5.3 million in a stock placement, the company stated in a filing with the Securities and Exchange Commission yesterday.
 
Third Wave Japan sold 7,112 shares of common stock at ¥90,000 ($743) per share to Mitsubishi, Shimadzu, CSK Institute for Sustainability, Daiichi Pure Chemicals, BML, and Toppan Printing.
 
Third Wave Japan said the investors purchased roughly 12.9 percent of its outstanding shares and around 12.4 percent of the company’s outstanding equity.
 
Including previous investments, Mitsubishi and CSK now own around 27 percent of Third Wave Japan, or 31 percent after exercise of warrants.
 
The company said the convertible Series A preferred stock has an 8-percent, non-cumulative dividend.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.